Delivery Order SPE2DB20D3103-SPE2DB25FP9D4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Alvimopan 12 mg capsule unit dose packages (30-count) on August 14, 2025, with a ceiling value of $26,853.88 and an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,935.50 to AmerisourceBergen Drug Corp for the supply of Alvimopan 12 mg capsules in unit dose packs of 30 units. This competitively awarded, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract does not include a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $11,346.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 unit-dose capsules of Alvimopan 12 mg, with a completion date of July 23, 2025. This non-set-aside competitive award reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The product is being delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a $4,959.12 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Alvimopan 12 mg capsule unit dose packages (30-count). This is a firm fixed price, non-set-aside contract with a completion date of August 8, 2025, and performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $5,167.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Alvimopan 12 mg capsule unit dose packets (30-count). This non-set-aside contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The delivery order represents a near-immediate fulfillment requirement typical of pharmaceutical supply chain operations...
- The Defense Logistics Agency awarded a delivery order valued at $22,903.32 to AmerisourceBergen Drug Corp for the supply of Alvimopan 12 mg capsules in unit dose packaging of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition. This delivery order is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,496.73 firm fixed price delivery order is for the supply of the pharmaceutical product Alvimopan 12 mg capsules, with a period of performance through April 2, 2024. Amerisourcebergen Drug Corp has an existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- The Defense Logistics Agency awarded a $4,937.71 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The order is for the supply of Alvimopan 12 mg capsules and has a completion date of February 14, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, to provide ALVIMOPAN 12 MG CAPSULE UD 30S. The contract has a potential value of $4,937.71 and a completion date of January 30, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, to provide 30-count unit dose packages of the drug Alvimopan 12 mg capsules. The $4,807.56 contract has a completion date of March 5, 2024. AmerisourceBergen Drug Corp is the prime contractor and does not have any major subcontractors listed. The contract was not set aside for any specific...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9D4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,809.76 to AmerisourceBergen Drug Corp for Alvimopan 12 mg capsule unit dose packs (30-count) on August 15, 2025. This firm fixed-price delivery order, with performance completion targeted for August 18, 2025, is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. The company's DLA IDC enables supply of a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. This specific delivery order for Alvimopan—a medication used to enhance recovery following intestinal surgery—represents a routine procurement from the company's established pharmaceutical inventory available through its prime vendor agreement with DLA Troop Support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 8/15/25 |